• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Prof. Masayoshi Harigai

Country: Tokyo Women's Medical University, Japan

Masayoshi Harigai, MD, PhD is Professor and Head of Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University, Tokyo, Japan. He served as Professor of Department of Pharmacovigilance at Tokyo Medical and Dental University between 2007 and 2015 and has been installed in the present position in 2019. Professor Harigai is the principal investigator of Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis, clinical trial of tocilizumab for ANCA-associated vasculitis, and 2020 Japanese Clinical Practice Guidelines for the Management of Rheumatoid Arthritis. He has been serving as a board member of Japan College of Rheumatology since 2018.

Share This Speaker

Key dates

More speakers

Prof. Rebecca Grainger

University of Otago, New Zealand

Prof Carol Langford

The Cleveland Clinic, United States
Ernest Choy

Prof. Ernest Choy

Cardiff University School of Medicine, United Kingdom
A/Prof Thaschawee Arkachaisri

A/Prof. Thaschawee Arkachaisri

Kk Women’s and Children’s Hospital, and Duke-nus Medical School, Singapore
Raphaela Goldbach-Mansky

Raphaela Goldbach-Mansky

Niaid, National Institutes of Health (NIH), United States
Puay Shi Ng

Puay Shi Ng

Tan Tock Seng Hospital, Singapore
Translate »